secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001104659-25-001087
Event type: other_material
Sentiment:  neutral
Materiality: 0.90
Item codes: 5.02, 3.02, 1.01, 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel: $3.1M private placement, CEO resigns, Lazar appointed interim CEO, board revamp, warrant exchange
--------------------------------------------------------------------------------

- David E. Lazar invests $3.1M for 1M Series C (convertible at 2.65:1) and 2.1M Series D (110:1) preferred shares.
- CEO Spiro Rombotis resigns; David Lazar appointed interim CEO; five directors resign, replaced by Natan and Ben-Tzvi.
- Company exchanges 24.8M warrants for 24.8M common shares plus $1.1M cash from an institutional holder.
- Special meeting by Feb 15, 2025 to vote on stock issuance, reverse split (1:4-1:16), authorized shares to 250M, equity plan increase.
- Proceeds used to repay liabilities and for general corporate purposes; cash must support at least three months post-closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/0001104659-25-001087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465925001087/tm251961d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-001087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer